Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID‐19
Arthritis & Rheumatology2020Vol. 73(5), pp. 731–739
Citations Over TimeTop 11% of 2020 papers
Joht Singh Chandan, Dawit Zemedikun, Rasiah Thayakaran, Nathan Byne, Samir Dhalla, Dionisio Acosta, Krishna Gokhale, Tom Thomas, Christopher Sainsbury, Anuradhaa Subramanian, Jennifer Cooper, Astha Anand, Kelvin Okoth, Jingya Wang, Nicola J. Adderley, Thomas Taverner, Alastair K. Denniston, Janet M. Lord, G. Neil Thomas, Christopher D. Buckley, Karim Raza, Neeraj Bhala, Krishnarajah Nirantharakumar, Shamil Haroon
Abstract
No increase in the risk of suspected or confirmed COVID-19 or mortality was observed among patients with OA in a primary care setting who were prescribed NSAIDs as compared to those who received comparator drugs. These results are reassuring and suggest that in the absence of acute illness, NSAIDs can be safely prescribed during the ongoing pandemic.
Related Papers
- → Effect of Bilateral Internal Mammary Artery Grafts on Long-Term Survival(2014)289 cited
- → The influence of bilateral internal mammary arteries on short- and long-term outcomes: A propensity score matching in accordance with current recommendations(2014)53 cited
- → Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis(2016)29 cited
- → Outcomes of simultaneous resection for elderly patients with colorectal liver metastasis: A propensity score matching analysis(2022)4 cited
- → Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin(2016)18 cited